ATE308890T1 - Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit - Google Patents

Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit

Info

Publication number
ATE308890T1
ATE308890T1 AT02739223T AT02739223T ATE308890T1 AT E308890 T1 ATE308890 T1 AT E308890T1 AT 02739223 T AT02739223 T AT 02739223T AT 02739223 T AT02739223 T AT 02739223T AT E308890 T1 ATE308890 T1 AT E308890T1
Authority
AT
Austria
Prior art keywords
shilajit
composition
purified
native
producing
Prior art date
Application number
AT02739223T
Other languages
English (en)
Inventor
Shibnath Ghosal
Original Assignee
Natreon Inc
Indian Herbs Res & Supply Comp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natreon Inc, Indian Herbs Res & Supply Comp filed Critical Natreon Inc
Application granted granted Critical
Publication of ATE308890T1 publication Critical patent/ATE308890T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
AT02739223T 2001-05-18 2002-05-03 Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit ATE308890T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/860,890 US6440436B1 (en) 2001-05-18 2001-05-18 Process for preparing purified shilajit composition from native shilajit
PCT/US2002/014259 WO2002094984A2 (en) 2001-05-18 2002-05-03 Process for preparing purified shilajit composition from native shilajit

Publications (1)

Publication Number Publication Date
ATE308890T1 true ATE308890T1 (de) 2005-11-15

Family

ID=25334290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02739223T ATE308890T1 (de) 2001-05-18 2002-05-03 Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit

Country Status (7)

Country Link
US (2) US6440436B1 (de)
EP (1) EP1387614B1 (de)
AT (1) ATE308890T1 (de)
AU (1) AU2002311886A1 (de)
DE (1) DE60207234T2 (de)
ES (1) ES2252467T3 (de)
WO (1) WO2002094984A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440436B1 (en) * 2001-05-18 2002-08-27 Natreon Inc. Process for preparing purified shilajit composition from native shilajit
US6558712B1 (en) * 2001-09-21 2003-05-06 Natreon Inc. Delivery system for pharmaceutical, nutritional and cosmetic ingredients
US20050085454A1 (en) * 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
EP1750739A4 (de) * 2004-04-14 2010-05-05 Natreon Inc Mit sauerstoff angereicherte dibenzo-alpha-pyron-chromoproteine
US20050233942A1 (en) * 2004-04-14 2005-10-20 Shibnath Ghosal Oxygenated dibenzo-alpha-pyrone chromoproteins
US20050282781A1 (en) * 2004-06-18 2005-12-22 Shibnath Ghosal Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
US7250181B2 (en) * 2005-01-19 2007-07-31 Natreon, Inc. Polyherbal compositions and methods for treating viral infections
CN100408653C (zh) * 2005-03-11 2008-08-06 吉林农业大学 土壤生物活化剂
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
CA2643579C (en) 2006-02-28 2018-05-15 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
KR100801057B1 (ko) * 2006-07-18 2008-02-04 삼성전자주식회사 컬러 보정 블럭을 구비하는 ｃｍｏｓ 이미지 센서 및 그이미지 센싱 방법
US8894993B2 (en) * 2006-08-04 2014-11-25 Natreon Inc. Mitochondria-targeted antioxidants
CL2009001956A1 (es) * 2009-10-09 2010-06-04 Neuroinnovation Spa Composicion nutracéutica que comprende extracto de shilajit (250-500 mg), acido folico (200-500 ug), vitamina b6(20-40 ug), vitamina b12 (4-8 ug) y excipientes aceptables; metodo de fabricacion; y su uso para prevenir o tratar la enfermedad de alzheimer.
US9872850B2 (en) 2010-12-23 2018-01-23 Amazentis Sa Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
US20120213756A1 (en) * 2011-02-21 2012-08-23 Rosemary Petralia Nutraceutical beverage
CA2877718C (en) 2012-06-27 2021-10-12 Amazentis Sa Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
CA2945495A1 (en) 2014-04-08 2015-10-15 Christopher VANDECAR Plant and animal extracts and related methods
US10183047B2 (en) 2014-05-21 2019-01-22 Natreon, Inc. Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
US20160095881A1 (en) * 2014-10-02 2016-04-07 Natreon, Inc. Promoting Muscle Building and Repair and Treating Disorders Related to Collagen and Pertinent Proteins by Using Shilajit
JP2017007951A (ja) * 2015-06-17 2017-01-12 公立大学法人岡山県立大学 ウロリチンを含有する光老化抑制剤
JP2017014154A (ja) * 2015-07-01 2017-01-19 公立大学法人岡山県立大学 ウロリチン類を含有するヒアルロン酸産生促進剤
JP6799767B2 (ja) * 2015-07-07 2020-12-16 公立大学法人岡山県立大学 ウロリチン類を含有するメラニン産生抑制剤
JP2017031108A (ja) * 2015-08-04 2017-02-09 公立大学法人岡山県立大学 ウロリチン類を含有する、抗しわ剤、コラーゲン産生促進剤、ｍｍｐ−１産生抑制剤、及びエラスターゼ活性阻害剤
US11292731B2 (en) 2017-02-02 2022-04-05 Christopher Vandecar Method and apparatus for treating contaminated fluid medium
KR20190134652A (ko) * 2017-03-08 2019-12-04 아마젠티스 에스에이 피부 치료 방법
US11969408B2 (en) 2017-03-08 2024-04-30 Amazentis Sa Method for improving mitophagy in subjects
KR101844849B1 (ko) 2017-07-27 2018-04-04 주식회사 제니버 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그 제조 방법
CA3104621C (en) * 2018-06-26 2022-02-08 Natreon, Inc. Improvement of blood microperfusion to skin by shilajit
CN109363956B (zh) * 2018-12-29 2022-05-13 广州市科能化妆品科研有限公司 喜来芝提取物的用途和美白水分露及其制备方法
WO2022040321A1 (en) * 2020-08-19 2022-02-24 Natreon, Inc. Protection against coronavirus infection by extracts and extract components

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405613A (en) * 1991-12-11 1995-04-11 Creative Nutrition Canada Corp. Vitamin/mineral composition
US6440436B1 (en) * 2001-05-18 2002-08-27 Natreon Inc. Process for preparing purified shilajit composition from native shilajit

Also Published As

Publication number Publication date
US20030039662A1 (en) 2003-02-27
US6869612B2 (en) 2005-03-22
AU2002311886A1 (en) 2002-12-03
EP1387614B1 (de) 2005-11-09
US6440436B1 (en) 2002-08-27
DE60207234D1 (de) 2005-12-15
ES2252467T3 (es) 2006-05-16
DE60207234T2 (de) 2006-08-03
WO2002094984A3 (en) 2003-03-06
EP1387614A2 (de) 2004-02-11
WO2002094984A2 (en) 2002-11-28
EP1387614A4 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
ATE308890T1 (de) Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit
BR0306846A (pt) Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido
DE50111495D1 (de) Künstliche sauerstoffträger aus vernetztem modifizierten human- oder schweinehämoglobin, verfahren zu ihrer herstellung aus gereinigtem material, sowie deren verwendung
DE60227951D1 (de) Delta-4-desaturase-gene und ihre verwendung
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ES2092266T3 (es) Composiciones para la nutricion ingeribles oralmente, que tienen apetibilidad mejorada.
ATE367810T1 (de) Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren
DE60026844D1 (de) Verfahren zur herstellung von 3,3-dimethylbutanal
ATE98473T1 (de) Orale praeparate gegen zahnbelaege.
DE60104457D1 (de) Verfahren zur Herstellung alpha, beta-ungesättigter Carbonsäureester sowie Katalysator zur Verwendung in diesem Verfahren
WO2005019256A3 (en) Muteins of tear lipocalin
DE59207907D1 (de) Benzopyranone, verfahren zu ihrer herstellung und verwendung
ATE243702T1 (de) Verfahren zur herstellung von ascorbinsäurederivaten
ES2194679T3 (es) Composiciones cosmeticas que contienen creatina, carnitina y/o acido piruvico.
ATE296791T1 (de) Verfahren zur herstellung von direkt tablettierbarem alpha-mannit
ATE294137T1 (de) Verfahren zur herstellung von orthokieselsäure, sowie nach dem verfahren hergestellte kieselsäure und ihre verwendung
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
ATE295716T1 (de) Mittel und verfahren zu dauerhaften haarverformung auf basis von 2- mercaptopropionsäureamiden sowie verfahren zu deren herstellung
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE326442T1 (de) Verfahren zur herstellung von essigsäure
ATE353669T1 (de) Allergievakzine sowie ihre herstellung
BR0017091A (pt) Uso de um composto, composição perfumante ou produto perfumado, composição aromatizante ou produto aromatizado, e, processo para conferir, aperfeiçoar, aumentar ou modificar as propriedades aromatizantes do tipo mandarina ou tangerina de uma composição aromatizante ou de um produto aromatizado
ATE248141T1 (de) Verfahren zur herstellung von (r) und (s)- aminocarnitin und deren derivative aus d- und l- aspargin säure
DE60204681D1 (de) Verfahren zur herstellung von 2-[4-(2,2,-dihalocyclopropyl)phenoxy]-alkansäuren und ihre estern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties